Clinical Focus ›› 2025, Vol. 40 ›› Issue (1): 39-43.doi: 10.3969/j.issn.1004-583X.2025.01.006
Previous Articles Next Articles
Lin Zexing1, Guo Hancheng1(), Yao Chunmeng1, Xiao Liangxiang1, Dai Yunxin1, Wu Sai1, Wang Fuzhen2, Xie Zugang3, Yao Cuiwei4
Received:
2024-08-30
Online:
2025-01-20
Published:
2025-01-17
Contact:
Guo Hancheng,Email:guohancheng@tom.comCLC Number:
Lin Zexing, Guo Hancheng, Yao Chunmeng, Xiao Liangxiang, Dai Yunxin, Wu Sai, Wang Fuzhen, Xie Zugang, Yao Cuiwei. Study on influencing factors and prevention for the complications of the “pull technique” technique for peritoneal catheter extubationremoval and the prevention[J]. Clinical Focus, 2025, 40(1): 39-43.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2025.01.006
项目 | 数值 |
---|---|
男性[例(%)] | 68(69.4) |
年龄(岁) | 52.3±13.6 |
体质量指数(kg/m2) | 22.0(20.3,23.0) |
导管使用时间(月) | 38.0(13.3,52.8) |
血清白蛋白(g/L) | 34.3(28.7,40.2) |
血红蛋白(g/L) | 99.3(83.1,107.9) |
C反应蛋白(mg/L) | 7.18(0.87,50.58) |
白细胞(×109/L) | 7.47(5.95,8.91) |
原发病因[例(%)] | |
糖尿病肾病 | 18(18.4) |
高血压肾病 | 18(18.4) |
慢性肾小球肾炎 | 52(53.1) |
梗阻性肾病 | 1(1.0) |
狼疮性肾病 | 3(3.1) |
慢性肾盂肾炎 | 1(1.0) |
尿酸性肾病 | 1(1.0) |
遗传性肾病 | 2(2.0) |
紫癜性肾炎 | 1(1.0) |
乙肝相关性肾病 | 1(1.0) |
拔管主要原因[例(%)] | |
腹膜炎 | 35(35.7) |
导管功能不良 | 10(10.2) |
转血液透析 | 25(25.5) |
腹膜功能障碍 | 14(14.3) |
渗漏和疝气 | 4(4.1) |
肾移植 | 10(10.2) |
Tab.1 Clinical characteristics
项目 | 数值 |
---|---|
男性[例(%)] | 68(69.4) |
年龄(岁) | 52.3±13.6 |
体质量指数(kg/m2) | 22.0(20.3,23.0) |
导管使用时间(月) | 38.0(13.3,52.8) |
血清白蛋白(g/L) | 34.3(28.7,40.2) |
血红蛋白(g/L) | 99.3(83.1,107.9) |
C反应蛋白(mg/L) | 7.18(0.87,50.58) |
白细胞(×109/L) | 7.47(5.95,8.91) |
原发病因[例(%)] | |
糖尿病肾病 | 18(18.4) |
高血压肾病 | 18(18.4) |
慢性肾小球肾炎 | 52(53.1) |
梗阻性肾病 | 1(1.0) |
狼疮性肾病 | 3(3.1) |
慢性肾盂肾炎 | 1(1.0) |
尿酸性肾病 | 1(1.0) |
遗传性肾病 | 2(2.0) |
紫癜性肾炎 | 1(1.0) |
乙肝相关性肾病 | 1(1.0) |
拔管主要原因[例(%)] | |
腹膜炎 | 35(35.7) |
导管功能不良 | 10(10.2) |
转血液透析 | 25(25.5) |
腹膜功能障碍 | 14(14.3) |
渗漏和疝气 | 4(4.1) |
肾移植 | 10(10.2) |
组别 | 例数 | 男性 [例(%)] | 年龄 (岁) | 体质量指数 (kg/m2) | 导管使用时间 (月) | 血清白蛋白 (g/L) | 血红蛋白 (g/L) | C反应蛋白 (mg/L) | 白细胞计数 (×109/L) |
---|---|---|---|---|---|---|---|---|---|
并发症组 | 13 | 6(46.2) | 47.1±13.1 | 26.3(24.7,27.1) | 47.0(23.5,80.5) | 29.9(27.6,37.3) | 88.0(77.5,107.5) | 45.30(1.30,75.3) | 9.90(6.90,12.90) |
无并发症组 | 85 | 62(72.9) | 52.9±13.9 | 21.3(19.6,22.4) | 29.0(13.0,51.0) | 35.2(30.7,40.8) | 101.0(84.0,108.0) | 1.35(0.80,46.80) | 7.10(5.80,8.30) |
2.650 | -1.472 | -5.534 | -1.650 | -1.380 | -1.032 | -1.995 | -2.760 | ||
0.103 | 0.144 | <0.001 | 0.099 | 0.167 | 0.302 | 0.046 | 0.006 |
Tab.2 Clinical data between complication and non-complication groups
组别 | 例数 | 男性 [例(%)] | 年龄 (岁) | 体质量指数 (kg/m2) | 导管使用时间 (月) | 血清白蛋白 (g/L) | 血红蛋白 (g/L) | C反应蛋白 (mg/L) | 白细胞计数 (×109/L) |
---|---|---|---|---|---|---|---|---|---|
并发症组 | 13 | 6(46.2) | 47.1±13.1 | 26.3(24.7,27.1) | 47.0(23.5,80.5) | 29.9(27.6,37.3) | 88.0(77.5,107.5) | 45.30(1.30,75.3) | 9.90(6.90,12.90) |
无并发症组 | 85 | 62(72.9) | 52.9±13.9 | 21.3(19.6,22.4) | 29.0(13.0,51.0) | 35.2(30.7,40.8) | 101.0(84.0,108.0) | 1.35(0.80,46.80) | 7.10(5.80,8.30) |
2.650 | -1.472 | -5.534 | -1.650 | -1.380 | -1.032 | -1.995 | -2.760 | ||
0.103 | 0.144 | <0.001 | 0.099 | 0.167 | 0.302 | 0.046 | 0.006 |
因素 | β | SE | Wald χ2值 | 95% | |||
---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||
体质量指数 | 2.199 | 0.837 | 6.900 | 9.015 | 0.009 | 1.740 | 46.500 |
白细胞计数 | 0.071 | 0.354 | 0.043 | 1.074 | 0.836 | 0.150 | 2.110 |
C反应蛋白 | 0.015 | 0.014 | 1.015 | 1.015 | 0.283 | 0.980 | 1.040 |
Tab.3 Multivariate logistic regression analysis for influencing factors of complications in PD patients after “pull” technique
因素 | β | SE | Wald χ2值 | 95% | |||
---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||
体质量指数 | 2.199 | 0.837 | 6.900 | 9.015 | 0.009 | 1.740 | 46.500 |
白细胞计数 | 0.071 | 0.354 | 0.043 | 1.074 | 0.836 | 0.150 | 2.110 |
C反应蛋白 | 0.015 | 0.014 | 1.015 | 1.015 | 0.283 | 0.980 | 1.040 |
组别 | 例数 | 男性 | 拔管主要原因 | ||||
---|---|---|---|---|---|---|---|
腹膜炎 | 转血液透析 | 腹膜功能障碍 | 导管功能不良 | 肾移植 | |||
本研究组 | 98 | 68(69.4) | 35(35.7) | 25(25.5) | 14(14.3) | 10(10.2) | 10(10.2) |
文献组 | 339 | 209(61.7) | 138(40.7) | 69(20.4) | 40(11.8) | 39(11.5) | 47(13.9) |
χ2值 | 1.960 | 0.793 | 1.197 | 0.434 | 0.129 | 0.898 | |
0.161 | 0.373 | 0.274 | 0.510 | 0.719 | 0.343 |
Tab.4 Clinical data between the cases reported in our study and literatures
组别 | 例数 | 男性 | 拔管主要原因 | ||||
---|---|---|---|---|---|---|---|
腹膜炎 | 转血液透析 | 腹膜功能障碍 | 导管功能不良 | 肾移植 | |||
本研究组 | 98 | 68(69.4) | 35(35.7) | 25(25.5) | 14(14.3) | 10(10.2) | 10(10.2) |
文献组 | 339 | 209(61.7) | 138(40.7) | 69(20.4) | 40(11.8) | 39(11.5) | 47(13.9) |
χ2值 | 1.960 | 0.793 | 1.197 | 0.434 | 0.129 | 0.898 | |
0.161 | 0.373 | 0.274 | 0.510 | 0.719 | 0.343 |
组别 | 例数 | 腹透管断裂 | 外cuff感染 | 内cuff感染 | 腹壁渗血 | 腹水渗漏 |
---|---|---|---|---|---|---|
本研究组 | 98 | 7(7.1) | 2(2.0) | 1(1.0) | 4(4.1) | 2(2.0) |
文献组 | 339 | 4(1.2) | 19(5.6) | 8(2.4) | 1(0.3) | 5(1.5) |
χ2值 | 8.720 | 1.404 | 0.175 | 6.580 | 0.000 | |
0.003 | 0.236 | 0.676 | 0.010 | 1.000 |
Tab.5 Postoperative complications between the cases reported in our study and literatures
组别 | 例数 | 腹透管断裂 | 外cuff感染 | 内cuff感染 | 腹壁渗血 | 腹水渗漏 |
---|---|---|---|---|---|---|
本研究组 | 98 | 7(7.1) | 2(2.0) | 1(1.0) | 4(4.1) | 2(2.0) |
文献组 | 339 | 4(1.2) | 19(5.6) | 8(2.4) | 1(0.3) | 5(1.5) |
χ2值 | 8.720 | 1.404 | 0.175 | 6.580 | 0.000 | |
0.003 | 0.236 | 0.676 | 0.010 | 1.000 |
组别 | 例数 | 腹透管断裂 | 外cuff感染 | 内cuff感染 | 腹壁渗血 | 腹水渗漏 |
---|---|---|---|---|---|---|
IPD组 | 35 | 2(5.7) | 2(5.7) | 1(2.9) | 3(8.6) | 1(2.9) |
NIPD组 | 63 | 5(7.9) | 0(0) | 0(0) | 1(1.6) | 1(1.6) |
χ2值 | 0.000 | 1.372 | 0.090 | 1.303 | 0.000 | |
1.000 | 0.241 | 0.764 | 0.254 | 1.000 |
Tab.6 Complications between IPD and NIPD groups
组别 | 例数 | 腹透管断裂 | 外cuff感染 | 内cuff感染 | 腹壁渗血 | 腹水渗漏 |
---|---|---|---|---|---|---|
IPD组 | 35 | 2(5.7) | 2(5.7) | 1(2.9) | 3(8.6) | 1(2.9) |
NIPD组 | 63 | 5(7.9) | 0(0) | 0(0) | 1(1.6) | 1(1.6) |
χ2值 | 0.000 | 1.372 | 0.090 | 1.303 | 0.000 | |
1.000 | 0.241 | 0.764 | 0.254 | 1.000 |
组别 | 例数 | 牵拉次数 | 牵拉角度 (°) | 牵拉力度 >15磅[例(%)] |
---|---|---|---|---|
腹透管断裂组 | 7 | 3(3,4) | 50(45,50) | 6(85.7) |
非腹透管断裂组 | 91 | 11(9,12) | 20(15,20) | 1(1.1) |
χ2/ | -4.430 | -4.707 | 57.988 | |
<0.001 | <0.001 | <0.001 |
Tab.7 Clinical data between PD catheter rupture and non-PD catheter rupture groups
组别 | 例数 | 牵拉次数 | 牵拉角度 (°) | 牵拉力度 >15磅[例(%)] |
---|---|---|---|---|
腹透管断裂组 | 7 | 3(3,4) | 50(45,50) | 6(85.7) |
非腹透管断裂组 | 91 | 11(9,12) | 20(15,20) | 1(1.1) |
χ2/ | -4.430 | -4.707 | 57.988 | |
<0.001 | <0.001 | <0.001 |
[1] | Kahveci A, Ari E, Asicioglu E, et al. Peritoneal dialysis catheter removal by nephrologists: Technical aspect from a single center[J]. Perit Dial Int, 2010, 30(5): 570-572. |
[2] | Hakim NS, Pirenne J, Benedetti E, et al. A technique of removal of the tenckhoff peritoneal dialysis catheter[J]. J Am Coll Surg, 1995, 180(3): 350-352. |
[3] | Crabtree JH, Shrestha BM, Chow KM, et al. Creating and maintaining optimal peritoneal dialysis access in the adult patient: 2019 update[J]. Perit Dial Int, 2019, 39(5): 414-436. |
[4] | 戴韵馨, 姚春萌, 关天俊, 等. “pull”技术腹膜透析拔管术3例报道及文献总结[J]. 中国中西医结合肾病杂志, 2020, 21(9): 795-797+850. |
[5] | Dai Y, Guo H, Li T, et al. Comparison between the 'pull technique' and open surgery for peritoneal catheter removal in Chinese patients on peritoneal dialysis[J]. Perit Dial Int, 2023, 43(2): 168-172. |
[6] | 程慧栋, 司博林, 华琴, 等. 腹膜透析导管徒手薅除术与手术切开拔管术的疗效对比[J]. 临床荟萃, 2021, 36(12): 1097-1101. |
[7] | 邵小娇, 胡军建, 张谊雯, 等. 腹膜透析导管两种不同拔除方法的临床观察[J]. 国际泌尿系统杂志, 2022, 42(1): 94-98. |
[8] | 张圣雪, 苏晓乐, 闫燕, 等. 两种不同腹膜透析导管拔除术在老年腹膜透析患者中的临床应用[J]. 中华老年医学杂志, 2022, 41(2): 191-195. |
[9] | Elkabir JJ, Riaz AA, Agarwal SK, et al. Delayed complications following Tenckhoff catheter removal[J]. Nephrol Dial Transplant, 1999, 14(6): 1550-1552. |
[10] | Quiroga IM, Baboo R, Lord RH, et al. Tenckhoff catheters post-renal transplantation: The 'pull' technique?[J]. Nephrol Dial Transplant, 2001, 16(10): 2079-2081. |
[11] | Grieff M, Mamo E, Scroggins G, et al. The 'pull' technique for removal of peritoneal dialysis catheters: A call for re-evaluation of practice standards[J]. Perit Dial Int, 2017, 37(2): 225-229. |
[12] |
成水芹, 陈赟敏, 周婷婷, 等. 体外徒手腹膜透析导管拔除术的临床应用[J]. 肾脏病与透析肾移植杂志, 2020, 29(6): 531-535.
doi: 10.3969/j.issn.1006-298X.2020.06.006 |
[13] |
Ding Q, Zhang B, Liu M, et al. Pull technique versus open surgical removal of the catheter for peritoneal dialysis:A retrospective cohort study[J]. Clin Exp Nephrol, 2022, 26(8): 827-834.
doi: 10.1007/s10157-022-02222-z pmid: 35426593 |
[14] | Nameirakpam S, Naorem SS, Naorem S. A simple sustained traction method for continuous ambulatory peritoneal dialysis (CAPD) catheter removal[J]. J Clin Diagn Res, 2016, 10(11): PL01. |
[15] | 姚春萌, 郭汉城, 戴韵馨, 等. Seldinger法穿刺置管联合Pull技术拔管更换腹膜透析导管1例[J]. 中国中西医结合肾病杂志, 2022, 23(5): 458+476. |
[16] | Zhang L, Ma X, Zheng Y, et al. Efficacy and safety of removing peritoneal dialysis catheters using the pull technique[J]. Int Urol Nephrol, 2024, 56(3): 1129-1135. |
[17] |
Zhang S, Zhang X, Li H, et al. Three cases of retained cuff related infection after manual pull removal of peritoneal dialysis catheter[J]. Ren Fail, 2021, 43(1): 58-61.
doi: 10.1080/0886022X.2020.1858872 pmid: 33349099 |
[18] | Wang J, Li XS, Zhang FX, et al. Minimally invasive 'pull technique' for peritoneal dialysis catheter removal[J]. Perit Dial Int, 2021, 41(1): 118-121. |
[19] |
Dimitriadis A, Antoniou S, Toliou T, et al. Tissue reaction to deep cuff of Tenckhoff's catheter and peritonitis[J]. Adv Perit Dial, 1990, 6: 155-158.
pmid: 1982798 |
[20] | Crabtree JH, Siddiqi RA. Simultaneous catheter replacement for infectious and mechanical complications without interruption of peritoneal dialysis[J]. Perit Dial Int, 2016, 36(2): 182-187. |
[21] | Antonio S, Luca N, Dalia Z, et al. Simultaneous replacement and removal of the peritoneal catheter is effective in patients with refractory tunnel infections sustained by S. aureus[J]. Int Urol Nephrol, 2023, 55(1): 151-155. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||